Evaluation of systolic blood pressure control in erderly patients with isolated systolic hypertension

European Review for Medical and Pharmacological Sciences

Volumn 10, Issue 3, 2006, Pages 111-114

  Pannarale, Giuseppe ^a   Licitra, R ^a   Leonetti, S ^a   Arrivi, A ^a   Corsi, F ^a   Gianturco, L ^a   Mirabelli, F ^a   Acconcia, M C ^a   Gaudio, C ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Elderly; Hypertension control; Systelic hypertension

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

AGE; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHI SQUARE TEST; CLINICAL PRACTICE; CONTROLLED STUDY; ECG ABNORMALITY; FEMALE; GENERAL PRACTITIONER; GERIATRIC CARE; HEART INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; MONOTHERAPY; PRACTICE GUIDELINE; PRESCRIPTION; PREVALENCE; QUANTITATIVE ANALYSIS; RANK SUM TEST; RETROSPECTIVE STUDY; RISK FACTOR; SEX RATIO; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; COMMUNITY MEDICINE; CROSS-SECTIONAL STUDIES; DIHYDROPYRIDINES; DRUG UTILIZATION; ELECTROCARDIOGRAPHY; FEMALE; HEALTH SERVICES FOR THE AGED; HUMANS; HYPERTENSION; MALE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; RETROSPECTIVE STUDIES; ROME; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 33746471214     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
2. Franklin SS, Jacobs MJ, Wong ND, L'Italien GJ, Lapuerta P. Predominance of isolated systolic hypertension among middle-age and elderly US Hypertensives: analysis based on National Health and Nutrition Examination (NHANES) III. Hypertension 2001; 37: 869-874.
3. Franklin SS, Larsan MG, Khan SA, Wong ND, Leip EP, Kannel WB, et al. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation 2001; 103: 1245-1249.
4. Izzo JL Jr, Levy D, Black HR. Clinical advisory statement. Importance of systolic blood pressure in older Americans. Hypertension 2000; 35: 1021-10214.
5. Kostis JB, Davis BR, Culter J, Grimm RH Jr, Berge KG, Cohen JD, Levy D. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Reseach Group. JAMA 1997; 278: 212-216.
6. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-3264.
7. Staessen JA, Thus L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, Mancia G, Nachev C, Palatini P, Parati G, Tuomilehto J, Webster J. Predicting Cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigator. JAMA 1999; 282: 539-546.
8. Lloyd-Jones DM, Evans JC, Larson MG, O'Donnell CJ, Roccella EJ, Levy D. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension 2000; 36: 594-599.
9. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-1053.
10. Primatesta P, Poulter NR. Hypertension management and control among English adults aged 65 years and older in 2000 and 2001. J Hypertens 2004; 22: 1093-1098.
11. Wing LM, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GLR, et al. A comparison of outcomes with angiotensin-convertng-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 2003; 348: 583-592.
12. Kjeldsen SE, Dahlöf B, Devereux RB, Julius S, Aurup P, Edelman J, et al. Effects of losartan on cardiovascular morbility and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy. JAMA 2002; 288: 1491-1498.
13. Malacco E, Vari N, Capuano V, Spagnuolo V, Borgnino C, Palatini P. A randomized, double-blind, active-controlled, parallel-group comparison of valsartan and amlodipine in the treatment of isolated systolic hypertension in elderly patients: the Val-Syst study. Clin Ther 2003; 25: 2765-2780.
14. Neutel JM, Weir MR, Moser M, Harris S, Edwards D, Michelson EL, Wang R, Action Study Investigators. ACTION Study Investigators. The Effects of Candesartan Cilexetil in Isolated Systolic Hypertension: A Clinical Experience Trial. J Clin Hypertens 2000; 2: 181-186.